Storia della carriera di John Green
Precedenti posizioni note di John Green
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| DICERNA PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 01/01/2016 | 01/05/2020 |
| REVO BIOLOGICS INC | Direttore Finanziario/CFO | - | - |
| VERASTEM, INC. | Direttore Finanziario/CFO | - | - |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
Posizioni
| Director of Finance/CFO | 3 |
Settori
| Health Technology | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| VERASTEM, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Dicerna Pharmaceuticals, Inc.
 Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to selectively silence genes that cause or contribute to disease. The firm uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas. The company was founded by Douglas M. Fambrough III, Mark A. Behlke, Roberto Guerciolini, James Craig Jenson, and John J. Rossi in October 2006 and is headquartered in Lexington, MA. | Health Technology |
rEVO Biologics, Inc.
 rEVO Biologics, Inc. BiotechnologyHealth Technology rEVO Biologics, Inc. engages in the development and commercialization of specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions. Its products include ATryn, which prevents blood clots during and after surgery and childbirth for patients with hereditary antithrombin deficiency. The company was founded in February 1993 and is headquartered in Framingham, MA. | Health Technology |
- Borsa valori
- Insiders
- John Green
- Esperienza
